Abstract Background Glioblastoma (GBM) is the most common brain tumor with the worst prognosis. Temozolomide is the only first-line drug for GBM. Unfortunately. the resistance issue is a classic problem. https://www.roneverhart.com/A-Pea-in-the-Pod-Clip-Down-Nursing-Bra-Black-L/